Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Delaying may preserve

After of , delaying may improve muscle, heart and lung recovery by preserving protective . Failure of to abolish the added benefit would reject the proposed dependence on this protein.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Ageing mechanism

Main connectionChronic inflammation

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Complement catalytic inhibition
Goal
Устойчивость восстановления к закреплению повреждённого состояния
Competing hypotheses
4
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
5 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
8 / 10Few new entities
8 / 10Decisive experiment
8 / 10Silver-bullet potential
4 / 10Support from research
Poster: Delayed uptake preserves complement inhibition
PosterOpen the sheet full size2026-10-01

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Immune response

    The and of apoptotic cells by phagocytes

    Where this hypothesis acts during recovery under blockade, before protective have formed

    Hypotheses on this target 8
    EfferocytosisInhibition. Hypotheses on this target 55Activation. Hypotheses on this target 22Function preservation. Hypotheses on this target 0Clearance restoration. Hypotheses on this target 11Immunosuppression. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0
    • Inhibition5
    • Activation2
    • Function preservation
    • Clearance restoration1
    • Immunosuppression
    • Feedback restoration
    • Rhythm restoration

    What is proposed

    Inhibition

    Selectively delay

    With whatNot stated in the record

    HowSelectively alter of whole while preserving vesicle formation and ; the specific intervention is not stated

    Possible result

    Possible additional improvement in muscle, heart and lung recovery through sustained protective vesicle production

    From the recordПоэтому избирательная задержка их поглощения должна усиливать многосистемную пользу подавления EP2.

  2. Receptor or channel

    receptor

    A receptor whose activity can be suppressed

    Where this hypothesis actsDuring recovery from injury, alongside selective inhibition of

    Hypotheses on this target 5
    EP2 receptorLower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Blockade. Hypotheses on this target 55Agonism. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function restoration. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Blockade5
    • Agonism
    • Desensitisation
    • Function restoration
    • Function preservation

    What is proposed

    Blockade

    Suppress receptor activity

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible multisystem recovery benefits enhanced by delaying

    From the recordПосле подавления рецептора простагландина E2 типа 2 (EP2)

  3. Immune response

    cascade

    An enzymatic cascade involved in immune responses

    Where this hypothesis actsExtracellularly during after

    Hypotheses on this target 1
    Complement cascadeInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Clearance restoration. Hypotheses on this target 0Immunosuppression. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Function preservation
    • Clearance restoration
    • Immunosuppression
    • Feedback restoration
    • Rhythm restoration

    What is proposed

    Inhibition

    Sustain extracellular inhibition of the cascade

    With whatProtein or peptide as the agent

    HowPreserve production of by delaying ; administer in the rescue experiment

    Possible result

    Possible shortening of the inflammation-resolution period SPV_3 and improved multisystem recovery

    From the recordОбщее причинное звено для потенциальной «серебряной пули» здесь представляет сохранение внеклеточного ингибирования комплемента.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαEP2 receptor. Hypotheses on this target 5EP2 receptor
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionEfferocytosis. Hypotheses on this target 8EfferocytosisComplement cascade. Hypotheses on this target 1Complement cascade
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Recovery from damage might depend on how long certain immune cells remain available to make protective material. The unexpected move is to propose that delaying their removal could improve recovery across muscle, heart and lungs, even though the preceding question considered restored removal a possible source of benefit. This is a mechanism generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. is proposed to change the environment around .
  2. That altered environment is proposed to let retained finish making -bearing .
  3. Delayed is proposed to keep producing protection instead of having that production cut short by early removal.
  4. The released are proposed to sustain inhibition of .
  5. Reduced activity is proposed to shorten the time inflammation takes to resolve.
  6. This protection is proposed to improve recovery in muscle, heart and lungs.
A picture for it

A repair crew may still be making protective covers when a cleanup team arrives to take it away. Leaving the crew in place longer helps only if it finishes useful covers during that extra time.

Where the picture breaks: Retained immune cells can also cause damage, and removing the cells is different from removing the packages they release. The picture does not establish that changes production or that the packages protect several organs.

  1. Master questionstep 01 of 04

    Processes involved in ageing may reinforce one another, so changing a shared cause could benefit several body systems at once.

    Rests on: The goal seeks a shared cause whose alteration could produce broad benefits for ageing.

    Assumption

    The search assumes that a shared causal link can be altered to benefit several systems. The supplied material does not establish such a link for ageing as a whole.

  2. Goal pillarstep 02 of 04

    Recovery should resist becoming stuck in a damaged state.

    Rests on: The broad search for benefits across systems is narrowed to the persistence of recovery.

    Assumption

    The stage takes resistance to a persistent damaged state as a useful focus for the search. The preceding goal does not explain why this property would provide a shared causal link.

  3. Gap questionstep 03 of 04

    Benefits across several systems might survive even when restored removal is selectively prevented. Such a result is posed as a possible challenge to removal as the shared cause of recovery.

    Rests on: The preceding focus on lasting recovery is narrowed to and the removal of .

    Leap

    The preceding stage supplies neither the choice of nor an established connection between , restored removal and benefits across systems. The supplied sources do not establish that connection. Preventing removal of whole cells would also leave removal of their released products as a competing explanation.

  4. Hypothesisstep 04 of 04

    retained after are proposed to finish producing , small membrane-enclosed packages released by cells, carrying . These packages would restrain , a chain of immune protein reactions that can contribute to damage. An altered environment around , immune cells that engulf cells and other material, is proposed to permit this production; early of would interrupt it.S5

    Rests on: The preceding question makes removal the point of comparison. The hypothesis supplies a reason delayed removal could help: retained cells would continue making protective packages. The screened Cell study from 2025 supports the narrower idea that persistent -derived can sustain deactivation in mouse pneumonia; it does not establish involvement, delayed removal of whole or benefits across several systems.

    Supported by literature

What is carried, and what is not. The Cell study from 2025 supports a narrow part of the mechanism: persistence of -derived sustained deactivation in a mouse pneumonia model, not through demonstrated retention of whole after . The Clinical Interventions in Aging study from 2025 identifies as a -regulating protein but does not establish the proposed protective route; no supplied source establishes the sequence from to lasting recovery across muscle, heart and lungs.

Where the reasoning is carried by something unstated · 3
  • Master question. The search assumes that a shared causal link can be altered to benefit several systems. The supplied material does not establish such a link for ageing as a whole.
  • Goal pillar. The stage takes resistance to a persistent damaged state as a useful focus for the search. The preceding goal does not explain why this property would provide a shared causal link.
  • Gap question. The preceding stage supplies neither the choice of nor an established connection between , restored removal and benefits across systems. The supplied sources do not establish that connection. Preventing removal of whole cells would also leave removal of their released products as a competing explanation. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Changing of whole could also change production or removal of their . Any recovery difference could then be credited to keeping cells alive and available when it actually reflects altered handling of released material. What closes it: The work must separately establish the change in whole-cell , vesicle production and vesicle removal. Confirmed and comparable initial damage are also required, as specified in the prediction.
  • Loss of the extra benefit after removing , followed by its return after vesicle delivery, could be treated as proof of even if vesicle abundance or other contents account for the effect. What closes it: activity must be measured alongside recovery and vesicle abundance. A comparison with otherwise comparable lacking functional is needed to attribute the returned benefit specifically to ; that comparison is not specified in the supplied test.
  • Early improvement in one organ could be read as recovery across systems while retained or displaced contribute to later damage elsewhere. What closes it: Muscle, heart and lung function must be assessed separately over time, with the observation period and criteria for sustained benefit fixed before results are examined. location must also be tracked to distinguish recovery from of damage.

What would make this wrong. With verified, initial damage comparable, whole- selectively delayed and vesicle production and removal preserved, failure of delayed to add recovery benefit would contradict the central prediction. If an added benefit remained after verified removal of from and loss of the proposed , it would contradict the claimed protective route even if another explanation still accounted for recovery.

What it would change. If the predicted loss and return of benefit held and were tied to , preserving protective output from retained immune cells would become a candidate shared cause of recovery. The search for a broadly effective ageing intervention would then have to distinguish removal of harmful material from premature removal of cells still making protection. Even that result would not establish longer life or durable benefits in ageing humans: the proposed test supplies no species or follow-up duration, and the directly relevant screened evidence concerns mouse pneumonia.

Sources read · 5

4 literature searches, 5 full texts, 1 abstract-only; 6 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Background

EP4 and EP2 receptor activation of protein kinase A by prostaglandin E2 impairs macrophage phagocytosis of Clostridium sordellii. · American journal of reproductive immunology (New York, N.Y. : 1989) · 2014

“Figure 2 EP2 and EP4 receptors mediate PGE 2 -induced intracellular cAMP increase and phagocytosis inhibition in THP-1 cells”

Does not settle: Источник не устанавливает влияние подавления EP2 на поглощение нейтрофилов, образование внеклеточных везикул с CD55, ингибирование комплемента, системную пользу или период разрешения воспаления SPV_3.

S2Background

PGE2 inhibits neutrophil phagocytosis through the EP2R-cAMP-PTEN pathway. · Immunity, inflammation and disease · 2022

“This study showed that PGE2 inhibited PMN phagocytosis of Escherichia Coli ( E. coli ) via the E‐series of prostaglandin receptors type 2 (EP2R)–cAMP–phosphatase and tensin homolog (PTEN) pathway.”

Does not settle: It does not examine macrophage uptake of neutrophils, extracellular vesicles, CD55, complement inhibition, inflammation-resolution time, or the effects of EP2 suppression.

S4Background

E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. · Prostaglandins & other lipid mediators · 2012

“In conclusion, these studies reinforce and refine the emerging paradigm that PGE 2 can impair innate immune function during severe infection and suggest that targeting specific receptors could help prevent or treat pneumococcal pneumonia.”

Does not settle: This source does not establish neutrophil uptake or its delay, neutrophil extracellular vesicles, CD55, complement inhibition, macrophage-mediated vesicle formation, multisystem benefit of EP2 suppression, or the SPV_3 inflammation-resolution period.

S5Partly answers it

Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution. · Cell · 2025

“Thus, do not eat me signals on LAND-Vs contributed to their prolonged residency in the lungs, ensuring sustained complement deactivation.”

Does not settle: This source does not test EP2 inhibition, altered macrophage environments, delayed uptake of neutrophils themselves, multisystem benefit, or SPV_3. Its in vivo evidence is from a mouse pneumonia model and concerns clearance of neutrophil-derived vesicles.

S6Background

Association of Decay Accelerating Factor (CD55) Positive Extracellular Vesicles with Advanced Age and Blood Glucose Levels in Elderly Individuals. · Clinical interventions in aging · 2025

“CD55 is a complement regulatory protein that has been linked to the progression of diabetes.”

Does not settle: This source does not establish that neutrophils produce CD55-positive vesicles, that their uptake is delayed, or any role for EP2 suppression, macrophages, complement-cascade inhibition by those vesicles, multisystem benefit, or SPV_3.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does suppressing a cell signal still benefit several body systems when improved removal of worn-out immune cells is blocked?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сохранится ли многосистемная польза , если избирательно воспрепятствовать восстановлению удаления , и опровергнет ли такой результат как общее причинное звено?

What this question is asking

The question asks whether improved removal of worn-out , a type of immune cell, is necessary for benefits across several body systems. The intervention suppresses signaling through E prostanoid receptor subtype 2 () in tissue-resident , immune cells that live in tissues and remove cellular material. The comparison is between that allows removal to improve and the same with that improvement selectively prevented. The question assumes that improves both removal and several aspects of health in aged mice, while treating removal as a possible shared cause of those benefits. It also asks whether benefits persisting when improved removal is blocked would disprove that proposed causal explanation.

What the terms mean
E prostanoid receptor subtype 2 (EP2)
A cell receptor through which prostaglandin E2 sends signals. The question concerns reducing its signaling in tissue-resident ; the supplied sources report different consequences of this signaling in different settings.
Prostaglandin E2
A signaling molecule that acts through receptors including . In the supplied sources, its signaling is linked to increased removal of dying cells, impaired bacterial killing, and protection against scarring, so its effects cannot be reduced to a single beneficial or harmful role.
Neutrophils
A type of immune cell. The question concerns removal of worn-out , rather than their production or every function they perform.
Senescent neutrophils
The aged or worn-out named in S1's title. The supplied material does not specify how that state was identified or whether it matches the dying-cell states studied in the other sources.
Tissue-resident macrophages
Immune cells that reside in tissues and can ingest cells and other material. They are the cells whose signaling was reduced in S1.
Clearance
Removal of cells or other material from a tissue. Here, the proposed causal step is improved removal of ; reduced accumulation alone would not specify how that reduction occurred.
Programmed cell death
An organized process through which cells die. The dying cells ingested in S6 should not automatically be treated as equivalent to every described as senescent in S1.
Mitochondrial fitness
The functional condition of mitochondria, structures within cells involved in supplying usable energy. S1 reports preservation of this condition but the supplied quotation does not specify its measurement.
Inflammation
A tissue and immune response to injury or threats. Body-wide inflammation is one of S1's reported outcomes, while the question asks whether improved cell removal explains its reduction.
Cognitive decline and frailty
Cognitive decline means worsening abilities such as memory and thinking; frailty means increased vulnerability associated with reduced physical reserves. Both are outcomes named in S1, but their measurement criteria are not supplied.
Hydrogen peroxide
A reactive chemical involved in the bacterial-killing mechanism described in S5. That source links reduced production of it to impaired bacterial killing.
Scarring
Formation of fibrous tissue, also called fibrosis. S8 concerns a possible loss of protection against this process in the uterine lining.
Selective prevention
The question's assumed ability to stop improvement in removal while keeping effective and avoiding other changes that could explain the outcomes. The supplied sources do not establish that this separation was achieved.
Necessary and sufficient causes
A necessary step must occur for a particular benefit to occur under the stated conditions. A sufficient step can produce that benefit on its own; showing necessity does not establish sufficiency.
What the question takes for granted
Premise only partly supported
Suppressing improves and condition in aged mice and produces benefits across several body systems, with proposed as their common causal link.

are immune cells, and tissue-resident are cells that can remove them as they become worn out. The assumption is that reducing signaling through a receptor on these improves their condition and removal work, alongside benefits elsewhere in the body. If established, that connection would provide the starting point for asking whether improved removal is required for those benefits.

S1 directly reports that reducing signaling in aged mice preserved mitochondrial fitness and prevented several adverse outcomes. Its title identifies restored of senescent as the subject, but the supplied abstract quotation does not detail that result or establish its necessity for the broader benefits. S6 reports increased of dying cells following activation in another setting, so a general claim that less signaling necessarily improves is not supported. None of the supplied passages establishes as the necessary common cause.S1S6

The same question asked without the part nothing read establishes:

  • In aged mice, do the benefits of reducing signaling persist when improved removal is selectively prevented?
  • Which benefits of reducing signaling in aged mice require improved removal?
What turns on the answer
  • Benefits persist across systems If improved removal were genuinely prevented while receptor remained effective, persistent benefits would mean that this improvement was not necessary for those measured benefits under those conditions. That would challenge restoration as their required common cause, while leaving possible contributions from existing or other settings unresolved.
  • Benefits disappear across systems Under the question's assumption of selective interference, losing the benefits would support a requirement for improved removal. It would not by itself establish that removal is the sole cause or that improving removal alone is sufficient to produce those benefits.
  • Some benefits persist and others disappear Under the same selectivity assumption, the outcomes would differ in their dependence on improved removal. restoration could then explain some benefits without serving as a necessary common link for every measured system.
Why it matters

The proposed chain runs from reduced receptor signaling to improved removal of worn-out immune cells, then to less inflammation and better function across several body systems. If improved removal is necessary, blocking that improvement would interrupt the chain despite continued receptor . If benefits persist, the proposed explanation would need to distinguish benefits that require improved removal from benefits that do not. Mistaking an accompanying change for a necessary cause would misidentify why the intervention works; assuming that receptor always helps would also overlook the opposing effects reported in other biological settings.

What is already established

улучшает и состояние у мышей, RL-1; необходимость для общего устойчивого эффекта отдельно не установлена.

What would have to be true

Воспаление и функции возвращаются в заданные диапазоны за дни или недели; повторные нагрузки сохраняют восстановление нескольких систем месяцами.

What is missing

Требуется разорвать предполагаемую причинную цепь и проверить, исчезает ли многосистемная польза при сохранённом воздействии на .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

После рецептора простагландина E2 типа 2 () главным источником устойчивой пользы становится сохранение , которые образуют защитные с белком . Предполагается, что изменённая среда позволяет этим завершить образование , подавляющих . Ускоренное преждевременно обрывает эту защиту. Поэтому избирательная задержка их должна усиливать многосистемную пользу . Общее причинное звено для потенциальной «серебряной пули» здесь представляет сохранение внеклеточного . Оно должно сокращать период SPV_3.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При подтверждённом и одинаковом исходном повреждении дополнительно улучшает восстановление мышцы, сердца и лёгких. Этот дополнительный выигрыш исчезает при -специфическом выключении и возвращается после введения . Напротив, независимое ускорение удаления при сохранённой ухудшает восстановление, если происходит до образования защитных . Простое сохранение пользы при для подтверждения этой гипотезы недостаточно.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies conditional improvements and worsening of recovery, plus loss and restoration of the additional benefit under specified interventions. These qualitative outcomes are measurable. No rival prediction was supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Выделение таких , оценка и этого белка в уже применялись. Главная экспериментальная трудность состоит в избирательном изменении целых при сохранении образования и удаления их .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При подтверждённом и одинаковом исходном повреждении дополнительно улучшает восстановление мышцы, сердца и лёгких. Этот дополнительный выигрыш исчезает при -специфическом выключении и возвращается после введения . Напротив, независимое ускорение удаления при сохранённой ухудшает восстановление, если происходит до образования защитных . Простое сохранение пользы при для подтверждения этой гипотезы недостаточно.

  • What would separate them

    Vesicle removal may limit damage from elastase shielded against its natural inhibitor predicts: При целых эффект сохраняется только при снижении количества с активной . Возврат таких устраняет пользу; равное количество с этого не делает. При одинаковой активности против свободной малый подавляет и восстанавливает функции эффективнее крупного . После отделения от поверхности размерная зависимость исчезает.

  • What would separate them

    Suppressing a prostaglandin receptor may curb ferroptosis through itaconate predicts: При и функции улучшаются на фоне сопоставимых количества , активности и внеклеточной . Одновременно снижаются и гибель . фермента синтеза устраняет этот выигрыш; прямое в восстанавливает его при продолжающейся . Отсутствие увеличения после опровергает предложенную связь.

  • What would separate them

    Shared lipid synthesis in neutrophils and platelets may limit tissue damage predicts: Польза сохраняется при и сопровождается усилением образования из . устраняет этот эффект при сохранённых количестве , активности на и . Введение соответствующего продукта синтеза восстанавливает функции. Отсутствие зависимости от тромбоцитарного фермента при подтверждённом его выключении опровергает гипотезу.

  • What would separate them

    Neutrophil movement may shift damage between organs and mimic lasting recovery predicts: После на фоне исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах. Раннее улучшение мышцы сопровождается отсроченным ухудшением лёгочной или сердечной функции после повторной обычной нагрузки. За заранее заданный период наблюдения согласованного функционального выигрыша трёх систем нет. Подтверждённое улучшение всех трёх систем на протяжении месяцев при отсутствии переноса опровергает эту гипотезу.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

В экспериментальной работе нейтрофильные сохранялись благодаря защите от , а их подавлял и повреждение лёгких. Это создаёт проверяемый конфликт между удалением нейтрофильного материала и сохранением его защитной функции. [Исследование нейтрофильных ](https://pmc.ncbi.nlm.nih.gov/articles/PMC11934499/).

Subfield revised

; учебная глава « и ». Пересмотра потребует , согласно которой ускоренное удаление стареющих обеспечивает . Гипотеза приписывает этому удалению противоположный знак в поздней фазе восстановления.

Testable surprise

Избирательное торможение удаления усиливает восстановление трёх систем после , тогда как восстановление их обращает этот выигрыш; обе зависимости определяются на .

Why this is not the mainstream account

Защитная функция нейтрофильных уже описана и сама по себе еретической не является. Радикальное утверждение здесь состоит в том, что ускоренный противодействует общему эффекту , а его блокада усиливает этот эффект. В просмотренных источниках такого утверждения не найдено; отсутствие его во всей литературе не установлено, поэтому статус HERETICAL остаётся предварительным.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.